search
Back to results

Randomized Control Trial of Second Stage of Labor

Primary Purpose

Labor Complications

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Length of Second Stage
Sponsored by
Thomas Jefferson University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Labor Complications focused on measuring randomized controlled trial, labor complications, cesarean section, second stage

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Nulliparous women
  • singleton pregnancies
  • cephalic presentation
  • 36.0-41.6 weeks
  • age 18 and older

Exclusion Criteria:

  • Category 3 fetal heart tracing
  • major congenital anomalies
  • multiples
  • planned cesarean delivery
  • intrauterine fetal demise
  • Trial of labor after cesarean

Sites / Locations

  • Thomas Jefferson University Hosptial

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Usual Labor

Extended

Arm Description

Immediate delivery after 3 hours with epidural or 2 hours without epidural

Immediate delivery after 4 hours with an epidural or 3 hours without an epidural Intervention: one additional hour for the second stage of labor Length of second stage in extended arm is 3 hours without epidural and 4 hours with epidural.

Outcomes

Primary Outcome Measures

Number of Patients Delivered by Cesarean
Number of patients delivered by cesarean delivery for the extended labor group

Secondary Outcome Measures

Number of Newborns With Umbilical Artery pH < 7.10
Umbilical artery pH is a marker for adverse neurological outcomes. Umbilical artery pH <7.10 has been proposed as a threshold for identifying fetuses who might develop pathologic fetal acidosis and fetal injury.
Postpartum Hemorrhage
Number of participants who experienced a postpartum hemorrhage

Full Information

First Posted
March 28, 2014
Last Updated
January 22, 2018
Sponsor
Thomas Jefferson University
search

1. Study Identification

Unique Protocol Identification Number
NCT02101515
Brief Title
Randomized Control Trial of Second Stage of Labor
Official Title
Randomized Control Trial of Usual Labor Versus Extended Second Stage
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
March 2014 (undefined)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
July 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Thomas Jefferson University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The hypothesis of this study is that extending the second stage of labor beyond current American College of Obstetricians and Gynecologists suggestions can reduce the cesarean delivery rate. The cesarean delivery rate in the United States is around 30 percent. This is a number that continues to be increasing over the last few decades and will continue to climb. Each subsequent cesarean section puts the mother and baby at increased risk for postpartum hemorrhage, bowel and bladder injury, abnormal placentation, febrile morbidity and death. The most common reason for a cesarean delivery is a repeat cesarean delivery. One way to reduce this number is to prevent the first cesarean delivery. The aim of this study is evaluate if extending the second stage of labor affects the cesarean delivery rate and subsequent perinatal morbidity.
Detailed Description
Consent at the time of admission or in the office 2nd stage starts at full dilation Randomization occurs at 2 hours without epidural or 3 hours with epidural, stratified by epidural status Randomization scheme is according to a predetermined computer-generated block randomization scheme with block sizes of 6,8 and12 (random blocks). Sequentially numbered and sealed opaque envelopes prepared according to the randomization scheme and delivered to a secure container in labor and delivery suite to maintain concealed treatment allocation. At the 3 hour mark, the next number envelope is pulled and opened by the physician/nurse to reveal the designated group. At this point the patient is considered randomized. Provider preference for cesarean delivery, operative vaginal delivery, continued pushing, with intention-to-treat analysis Those that require cesarean delivery - usual perioperative management Early termination criteria: emergency cesarean delivery, category 3 fetal heart tracing

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Labor Complications
Keywords
randomized controlled trial, labor complications, cesarean section, second stage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
78 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Labor
Arm Type
Placebo Comparator
Arm Description
Immediate delivery after 3 hours with epidural or 2 hours without epidural
Arm Title
Extended
Arm Type
Experimental
Arm Description
Immediate delivery after 4 hours with an epidural or 3 hours without an epidural Intervention: one additional hour for the second stage of labor Length of second stage in extended arm is 3 hours without epidural and 4 hours with epidural.
Intervention Type
Other
Intervention Name(s)
Length of Second Stage
Intervention Description
The experimental group will have one additional hour in the second stage of labor
Primary Outcome Measure Information:
Title
Number of Patients Delivered by Cesarean
Description
Number of patients delivered by cesarean delivery for the extended labor group
Time Frame
At time of delivery, up to 4 hours of the second stage for "Extended group" and 3 hours for "Usual group"
Secondary Outcome Measure Information:
Title
Number of Newborns With Umbilical Artery pH < 7.10
Description
Umbilical artery pH is a marker for adverse neurological outcomes. Umbilical artery pH <7.10 has been proposed as a threshold for identifying fetuses who might develop pathologic fetal acidosis and fetal injury.
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Postpartum Hemorrhage
Description
Number of participants who experienced a postpartum hemorrhage
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Other Pre-specified Outcome Measures:
Title
Operative Vaginal Delivery
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Spontaneous Vaginal Delivery
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Endometritis
Description
Clinical diagnosis of postpartum endometritis of the mother
Time Frame
at time of delivery until maternal discharge, usually < 5 days
Title
Transfusion
Description
Any transfusion of packed red blood cells to the mother or any other blood products given.
Time Frame
at time of delivery until maternal discharge, usually < 5 days
Title
3rd/4th Degree Laceration
Description
3rd or 4th degree laceration or cervical laceration diagnosed at delivery Third degree lacerations extend through the fascia and musculature of the perineal body and involve some or all of the fibers of the external anal sphincter (EAS) and/or the internal anal sphincter. Third degree lacerations are subclassified as follows: 3a: <50 percent of EAS thickness is torn 3b: >50 percent of EAS thickness is torn 3c: IAS is torn (in addition to complete rupture of the EAS) Fourth degree lacerations involve the perineal structures, EAS, IAS, and the rectal mucosa.
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Number of Participants With Shoulder Dystocia
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Neonatal Intensive Care Unit Admission (Neonates)
Description
One neonate was analyzed per mother
Time Frame
Birth until neonatal discharge
Title
Chorioamnionitis
Description
Clinical diagnosis of Chorioamnionitis of the mother
Time Frame
at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual"
Title
Neonatal Sepsis (Neonate)
Description
Diagnosed by neonatology, one neonate was analyzed per mother
Time Frame
until neonatal discharge, usually < 5 days
Title
Birth Weight (Neonate)
Description
One neonate was analyzed per mother
Time Frame
at time of delivery
Title
Neonatal Seizures (Neonate)
Description
Diagnosed by neonatology, one neonate was analyzed per mother
Time Frame
until discharge, usually < 5 days
Title
Neonatal Length of Stay (Neonate)
Description
one neonate was analyzed per mother
Time Frame
until neonatal discharge, usually < 5 days
Title
Neonatal Mortality (Neonate)
Description
one neonate was analyzed per mother
Time Frame
early neonatal mortality (within 7 days of birth).
Title
Continuous Positive Airway Pressure or Greater (Neonate) Such as Intubation, Mechanical Ventilation, Nasal Intermittent Positive Pressure Ventilation, High-frequency Oscillatory Ventilation
Description
Number of neonates who required continuous positive airway pressure or greater.
Time Frame
Until neonatal discharge, usually < 5 days

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Nulliparous women singleton pregnancies cephalic presentation 36.0-41.6 weeks age 18 and older Exclusion Criteria: Category 3 fetal heart tracing major congenital anomalies multiples planned cesarean delivery intrauterine fetal demise Trial of labor after cesarean
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexis Gimovsky, MD
Organizational Affiliation
Thomas Jefferson University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vincenzo Berghella, MD
Organizational Affiliation
Thomas Jefferson University
Official's Role
Study Chair
Facility Information:
Facility Name
Thomas Jefferson University Hosptial
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Please contact Dr. Gimovsky at agimovsky@mfa.gwu.edu
Citations:
PubMed Identifier
33586572
Citation
Gimovsky AC, Phillips JM, Amero M, Levine J, Berghella V. Prolonged second stage effect on pelvic floor dysfunction: a follow up survey to a randomized controlled trial. J Matern Fetal Neonatal Med. 2022 Dec;35(25):5520-5525. doi: 10.1080/14767058.2021.1887122. Epub 2021 Feb 14.
Results Reference
derived
PubMed Identifier
26928148
Citation
Gimovsky AC, Berghella V. Randomized controlled trial of prolonged second stage: extending the time limit vs usual guidelines. Am J Obstet Gynecol. 2016 Mar;214(3):361.e1-6. doi: 10.1016/j.ajog.2015.12.042.
Results Reference
derived

Learn more about this trial

Randomized Control Trial of Second Stage of Labor

We'll reach out to this number within 24 hrs